mabthera ®100mg/10ml infusion
city medical store - sole proprietorship l.l.c switzerland - 10 ml vial x 2 - infusion - 100mg/10ml - malignant disease,immunosuppresion-immune response
mabthera® sc 1400mg 1400mg/13.4ml parenteral ordinary s c vials
f.hoffmann-la roche ltd - rituximab - parenteral ordinary s c vials - 1400mg/13.4ml
mabthera® 100mg/10ml 100mg/10ml parenteral ordinary infusion vials/bottles
f. hoffmann la-roche - rituximab - parenteral ordinary infusion vials/bottles - 100mg/10ml
mabthera® 500mg/50ml 500mg/50ml parenteral ordinary infusion vials/bottles
f. hoffmann la-roche - rituximab - parenteral ordinary infusion vials/bottles - 500mg/50ml
mabthera 100 injection
f. hoffman-la roche ltd capitol hill towerscathedral road. p.o. box - rituximab - injection - rituximab - other antineoplastic agents: monoclonal antibodies
mabthera 500 injection
f. hoffman-la roche ltd capitol hill towerscathedral road. p.o. box - rituximab - injection - rituximab 500mg - other antineoplastic agents: monoclonal antibodies
mabthera sc 1400
roche products (pty) ltd - rituximab - injection - each vial contains rituximab 1400mg/11.7ml
mabthera sc 1600
roche products (pty) ltd - rituximab - injection - each via contains rituximab 1600mg/13.4ml
mabthera 100 mg
roche products sa (pty) ltd - rituximab - concentrate for solution for infusion - each single-use 10ml vial contains rituximab 100,0 mg
mabthera 500 mg
roche products sa (pty) ltd - rituximab - concentrate for solution for infusion - each single-use 50ml vial contains rituximab 500,0 mg